Bonus Material-Less Common Pulmonary Diseases I

Pdf Summary

Jay H. Ryu’s presentation from the Mayo Clinic discusses less common pulmonary diseases, specifically focusing on diffuse cystic lung diseases in Part 1. The session's learning objectives include understanding rare (orphan) diseases, identifying causes and presentations of uncommon pulmonary disorders, and recognizing diagnostic and management strategies.<br /><br />Rare diseases, per the US Orphan Drug Act of 1983, affect fewer than 200,000 people in the US, totaling about 25 million across 7,000 different illnesses. Diagnosis often requires broad differential diagnosis, clinical context recognition, and imaging features.<br /><br />Diffuse cystic lung diseases are characterized by cysts, which are round lucencies in lung parenchyma, and cavities, thick-walled lucencies within lung masses or nodules. Major causes include:<br /><br />1. <strong>Lymphangioleiomyomatosis (LAM)</strong>: Mostly in women, often linked to TSC (tuberous sclerosis complex). It presents with cysts on HRCT (high-resolution computed tomography), involves lymphangioleiomyomatosis cells (HMB-45 marker), and is treated with sirolimus or lung transplant.<br />   <br />2. <strong>Pulmonary Langerhans Cell Histiocytosis (PLCH)</strong>: Typically affects young adult smokers, presenting with bronchiolocentric, destructive lesions, and Langerhans cells marked by CD1a and langerin. Management involves smoking cessation and potential drug treatments like B-raf inhibitors for those with BRAF-V600E mutation.<br /><br />3. <strong>Birt-Hogg-Dubé (BHD) Syndrome</strong>: A rare autosomal dominant condition characterized by lung cysts, skin lesions (fibrofolliculomas), and a high propensity for renal tumors. Diagnosis is based on genetic testing and clinical presentation, with management focused on monitoring and treating pneumothoraces.<br /><br />4. <strong>Lymphoid Interstitial Pneumonia (LIP)</strong>: Associated with immunodeficiencies and connective tissue diseases (CTDs), presenting with ground-glass opacities and small nodules on imaging.<br /><br />5. <strong>Amyloidosis</strong>: Systemic in nature, involving abnormal protein deposits, presenting differently but also covered in later parts of the lecture dedicated to other systemic manifestations.<br /><br />Other rare causes include light chain deposition disease and heritable disorders like Marfan Syndrome and Neurofibromatosis type 1. The session emphasizes that understanding and distinguishing these conditions often relies on imaging patterns and specific markers, and managing them involves targeted therapies based on the underlying disease mechanisms.

Meta Tag

Concept Rare Disease

Concept Diffuse Cystic Lung Disease

Concept Lymphangioleiomyomatosis

Concept Pulmonary Langerhans Cell Histiocytosis

Concept Differential Diagnosis

Keywords

diffuse cystic lung disease

lymphangioleiomyomatosis

pulmonary langerhans cell histiocytosis

birt-hogg-dube syndrome

lymphoid interstitial pneumonia

amyloidosis

orphan diseases

high-resolution computed tomography

pneumothorax

genetic testing

Rare Disease

Diffuse Cystic Lung Disease

Lymphangioleiomyomatosis

Pulmonary Langerhans Cell Histiocytosis

Differential Diagnosis